4-bromo-1-hexene | 58794-27-7

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 有机溴化物
• 英文名称: 4-bromo-1-hexene
• 英文别名: 4-bromohex-1-ene
• CAS: 58794-27-7
• 化学式: C₆H₁₁Br
• 分子量: 163.057
• InChiKey: GNQKXXPCKOEGKS-UHFFFAOYSA-N

物化性质

• 熔点：
  -102.35°C (estimate)
• 沸点：
  138.85°C (estimate)
• 密度：
  1.2129 (estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  7
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为反应物：
  描述：

  二甲基丙二酸钠 、 4-bromo-1-hexene 以 甲醇 为溶剂， 反应 10.0h， 以9 g的产率得到dimethyl (1-hexen-4-yl)-malonate
  参考文献：
  名称：

  A further study of the bile acids in infants with coprostanic acidemia

  摘要：

  The structure of the bile acids in serum of infants with coprostanic acidemia was further investigated. The identity of 3 alpha-hydroxy-5 beta-cholestan-26-oic acid and 3 beta-hydroxy-5-cholesten-26-oic acid was confirmed. The biosynthesis of the 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-C29 dicarboxylic bile acid does not start from beta-sitosterol.

  DOI：

  10.1016/0039-128x(81)90010-6

文献信息

• Process for Production of 5-Alkoxy-4-Hydroxymethylpyrazole Compound
  申请人：Uchida Yukio

  公开号：US20090036688A1

  公开（公告）日：2009-02-05

  The present invention relates to a process for producing a 5-alkoxy-4-hydroxymethylpyrazole compound represented by the general formula (3) which comprises reacting a pyrazole compound represented by the general formula (1) (wherein R 1 is a substituent such as alkyl group, substituted or unsubstituted group or the like, and R 2 is an electron withdrawing group) with a compound represented by the general formula (2) L-R 3 (2) (wherein L is a leaving group and R 3 is a substituent such as substituted or unsubstituted alkyl group or the like) in the presence of a base and formaldehyde.

  本发明涉及一种制备5-烷氧基-4-羟甲基吡唑化合物的方法，该化合物由通式（3）表示，其中，该方法包括在碱和甲醛的存在下，将通式（1）所表示的吡唑化合物（其中，R1是取代基，例如烷基，取代或未取代基或类似基团，而R2是电子提取基团）与通式（2）所表示的化合物L-R3（2）（其中，L是离去基团，而R3是取代或未取代的烷基或类似基团）反应。
• PROCESS FOR PRODUCTION OF 5-ALKOXY-4-HYDROXYMETHYLPYRAZOLE COMPOUND
  申请人：IHARA CHEMICAL INDUSTRY CO., LTD.

  公开号：EP1990336B1

  公开（公告）日：2012-02-08
• US7812175B2
  申请人：——

  公开号：US7812175B2

  公开（公告）日：2010-10-12
• [EN] (CO)POLYMER MODIFICATION EMPLOYING UNSATURATED t-ALKYL PEROXY ALKENES
  申请人：AKZO N.V.

  公开号：WO1991000300A1

  公开（公告）日：1991-01-10

  (EN) Novel organic unsaturated tertiary alkyl peroxy alkenes are disclosed and a process of modifying (co)polymers employing these peroxy alkenes is also disclosed. (Co)polymers are modified by contacting them with one or more of these organic peroxides and decomposing the peroxide. By this process the physical properties of the (co)polymers, such as adhesion to polar substrates and lap shear strength, can be enhanced. According to a preferred embodiment, the modification reaction is carried out in the presence of a coagent whereby the advantageous polymer properties, such as adhesion to polar materials, are further enhanced. Also disclosed are shaped objects manufactured using the modified (co)polymers prepared by the process of the present invention.(FR) Sont décrits de nouveaux peroxy alkylènes d'alkyles tertiaires organiques insaturés ainsi qu'un procédé pour modifier des (co)polymères au moyen de ces peroxy alkylènes. On modifie des (co)polymères en les mettant en contact avec un ou plusieurs de ces peroxydes organiques et en décomposant le peroxyde. Ce procédé permet d'améliorer les caractéristiques physiques des (co)polymères, telles que l'adhérence à des substrats polaires et la résistance au cisaillement de chevauchement. Selon un mode préféré de réalisation, la réaction de modification s'effectue en présence d'un coagent, les caractéristiques polymères avantageuses, telles que l'adhérence à des matériaux polaires, étant encore améliorées. Sont également décrits des objets façonnés fabriqués à l'aide des (co)polymères modifiés préparés par le procédé de la présente invention.
• A further study of the bile acids in infants with coprostanic acidemia
  作者：G. Janssen、G. Parmentier

  DOI：10.1016/0039-128x(81)90010-6

  日期：1981.1

  The structure of the bile acids in serum of infants with coprostanic acidemia was further investigated. The identity of 3 alpha-hydroxy-5 beta-cholestan-26-oic acid and 3 beta-hydroxy-5-cholesten-26-oic acid was confirmed. The biosynthesis of the 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-C29 dicarboxylic bile acid does not start from beta-sitosterol.